CONTENTS:
- Perceived and misperceived norms about khat and/or cannabis use among adults in southwest Uganda. Perkins J.M., Kakuhikire B., Baguma C., Meadows M., Evans C.Q., Jurinsky J., et al., art. 103527.
- Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study. Cossar R.D., Stewart A.C., Wilkinson A.L., Dietze P., Ogloff J.R.P., Aitken C., et al., art. 103532.
- Uncertainty and risk: A framework for understanding pricing in online drug markets. Munksgaard R., Tzanetakis M., art. 103535.
- Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey. Saloner B., Krawczyk N., Solomon K., Allen S.T., Morris M., Haney K., et al., art. 103537.
- Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014-2020. Bach P., Bawa M., Grant C., Milloy M.J., Hayashi K., art. 103545.
- Queering poppers literature: A critical interpretive synthesis of health sciences research on alkyl nitrite use and Canadian policy. Schwartz C., Tooley L., Knight R., Steinberg M., art. 103546.
- 'Pretty in Pink' and 'Girl Power': An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram. Atkinson A.M., Meadows B.R., Emslie C., Lyons A., Sumnall H.R., art. 103547.
- Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic-Is an update of legal restrictions warranted? Meyer M., Strasser J., Köck P., Walter M., Vogel M., Dürsteler K.M., art. 103548.
- Key considerations for the implementation of clinically focused Prescription Drug Monitoring Programs to avoid unintended consequences. Haines S., Savic M., Nielsen S., Carter A., art. 103549.
- The killing of social leaders: An unintended effect of Colombia's illicit crop substitution program. Marin Llanes L., art. 103550.
- The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months. Bennett A.S., Townsend T., Elliott L., art. 103554.
- Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States. Chen Q., Sterner G., Segel J., Feng Z., art. 103555.
- Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions. Salamanca-Buentello F., Cheng D.K., Sabioni P., Majid U., Upshur R., Sud A., art. 103556.
- Public interest in ?8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ?9-Tetrahydrocannabinol (delta-9-THC) use. Leas E.C., Nobles A.L., Shi Y., Hendrickson E., art. 103557.
- Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program. Bachireddy C., Shrestha R., Bromberg D.J., Azbel L., Kurmanalieva A., Wegman M., et al., art. 103558.
- Public support for further regulating smoking, snus and e-cigarettes in Norway, and its associations with risk perceptions and tobacco use. Saebo G., Lund I., art. 103559.
- 'What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40-65 years in Australia. Wright C.J.C., Miller M., Kuntsche E., Kuntsche S., art. 103560.
- Drug markets and COVID-19: A spatiotemporal study of drug offence detection rates in Brisbane, Australia. Payne J.L., Langfield C.T., art. 103561.
- The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study. Carrilero N., Mora T., Garcia-Altés A., art. 103562.
- Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries. Davies E.L., Puljevic C., Gilchrist G., Potts L., Zhuparris A., Maier L.J., et al., art. 103563.
- Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Sivakumar A., Madden L., DiDomizio E., Eller A., Villanueva M., Altice F.L., art. 103570.
- "It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success. Schroeder S.E., Drysdale K., Lafferty L., Baldry E., Marshall A.D., Higgs P., et al., art. 103571.
- Investigating opioid preference to inform safe supply services: A cross sectional study. Ferguson M., Parmar A., Papamihali K., Weng A., Lock K., Buxton J.A., art. 103574.
- A matter of craving - An archeology of relapse prevention in Swedish addiction treatment. Ekendahl M., Karlsson P., art. 103575.
- A systematic narrative review of the effects of alcohol supply reduction policies on children and adolescents. Baldwin R., Miller P.G., Coomber K., Patafio B., Scott D., art. 103581.